Moderna, Inc. (NASDAQ:MRNA)

PRESS RELEASE

published on 09/16/2025 at 12:00, 7 months 16 days ago

Moderna Announces Updated COVID-19 Vaccine Against LP.8.1 Variant Generates Strong Immune Response in Humans
Moderna reports 8-fold increase in neutralizing antibodies with Spikevax 2025-2026 formula, reinforcing FDA approval. Clinical trial data supports efficacy against COVID-19 LP.8.1 variant

FDA Approval COVID-19 Vaccine Moderna Spikevax Neutralizing Antibodies
BRIEF

published on 09/02/2025 at 13:05, 8 months ago

Moderna to Present mRNA Therapeutics Data at 2025 ICIEM

MRNA Therapeutics Moderna Propionic Acidemia ICIEM Methylmalonic Acidemia
PRESS RELEASE

published on 09/02/2025 at 13:00, 8 months ago

Moderna Announces Data to be Presented at the 2025 International Congress of Inborn Errors of Metabolism
Moderna, Inc. to present abstracts on mRNA therapeutics at the 2025 ICIEM including PA, MMA, and GSD1a programs in Kyoto, Japan. Company's first time presenting data for MMA and GSD1a

Moderna Inc. MRNA Therapeutics ICIEM Abstracts Kyoto Japan
BRIEF

published on 08/27/2025 at 19:29, 8 months 6 days ago

Moderna's Updated COVID-19 Vaccines Approved by U.S. FDA

FDA Approval COVID-19 Vaccine Moderna SARS-CoV-2 Variant Spikevax And MNEXSPIKE
PRESS RELEASE

published on 08/27/2025 at 19:24, 8 months 6 days ago

Moderna Receives U.S. FDA Approval for Updated COVID-19 Vaccines Targeting LP.8.1 Variant of SARS-CoV-2
Moderna announces FDA approval for updated Spikevax® and mNEXSPIKE® COVID-19 vaccines targeting LP.8.1 variant to prevent severe outcomes. Vaccines available soon

FDA Approval Moderna COVID-19 Vaccines Spikevax MNEXSPIKE
BRIEF

published on 08/22/2025 at 15:30, 8 months 11 days ago

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine

COVID-19 Vaccine Moderna Health Canada Approval Canadian Manufacturing Biomanufacturing Leadership
PRESS RELEASE

published on 08/22/2025 at 15:25, 8 months 11 days ago

Moderna Receives Health Canada Approval for Updated COVID-19 Vaccine Targeting SARS-CoV-2 Variant LP.8.1
Moderna's Spikevax COVID-19 vaccine for SARS-CoV-2 LP.8.1 variant authorized in Canada, with all 2025 doses produced domestically. Leadership in biomanufacturing highlighted

COVID-19 Vaccine Canada Moderna Spikevax Biomanufacturing
BRIEF

published on 08/21/2025 at 13:05, 8 months 12 days ago

Moderna to Participate in Major September 2025 Conferences

Investor Conferences MRNA Medicine Moderna Live Webcast Healthcare Presentation
PRESS RELEASE

published on 08/21/2025 at 13:00, 8 months 12 days ago

Moderna to Present at Upcoming Conferences in September 2025
Moderna, Inc. to participate in upcoming investor conferences. The company's innovative mRNA technology redefines medicine creation, focusing on infectious diseases, oncology, and more

Investor Conferences Healthcare COVID-19 Vaccine MRNA Technology Moderna
BRIEF

published on 08/01/2025 at 13:05, 9 months 1 day ago

Moderna's Q2 2025 Financial Results and Business Updates

Cost Management FDA Approvals Q2 2025 Revenue Moderna Financial Results Vaccine Sales

Published on 05/02/2026 at 21:00, 3 hours 9 minutes ago

GECC Subsidiary Provides Update on its Lawsuit for Damages Against the Lender of the Atmosphere Project
Published on 05/02/2026 at 01:30, 22 hours 39 minutes ago

Uraniumx Reports Strong Financial Position Ahead of Spring Drill Program
Published on 05/02/2026 at 00:50, 23 hours 19 minutes ago

CoTec Announces Annual Stock Option, Restricted Share Unit And Deferred Share Unit Grants
Published on 05/02/2026 at 00:00, 1 day ago

Redwood AI Announces Enhanced AI Models, Increasing Evaluated Chemical Reactions Following Preliminary Results from UBC Collaboration
Published on 05/02/2026 at 00:00, 1 day ago

Onco-Innovations Expands Manufacturing Scale-Up of Its PNKP Inhibitor Technology with Dalton Pharma Services, Advancing Multi-Kilogram Non-GMP Synthesis to Support IND-Enabling Studies

View all ACCESSWIRE

Published on 05/02/2026 at 15:35, 8 hours 33 minutes ago

Ecuador's banana sector renews labor agreement, with jobs meeting global standards
Published on 05/01/2026 at 19:23, 1 day 4 hours ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/01/2026 at 18:40, 1 day 5 hours ago

Holding(s) in Company
Published on 05/01/2026 at 17:47, 1 day 6 hours ago

Key Figures 30.04.2026
Published on 05/01/2026 at 17:45, 1 day 6 hours ago

Burkhalter Group acquires Progressio Holding GmbH and anplaq ag, Tamins (GR)

View all EQS

Published on 04/30/2026 at 20:00, 2 days 4 hours ago

AMA Corp PLC : FY 2025 Earnings & Q1 2026 Revenue
Published on 04/30/2026 at 19:16, 2 days 4 hours ago

AXA announces the results of its Shareholders' Meeting
Published on 04/30/2026 at 19:00, 2 days 5 hours ago

Capital increase through exercise of subscription rights
Published on 04/30/2026 at 18:10, 2 days 5 hours ago

Minutes of the Combined General Meeting held on April 30, 2026
Published on 04/30/2026 at 18:00, 2 days 6 hours ago

TF1 Q1 2026 results - Press release

View all LES ECHOS COMFI WIRE

News